Allergy medication recalled over potentially ‘life-threatening’ cross-contamination

to be removed from the market amid a safety investigation. Some products were found to have low levels of N-Nitrosodimethylamine, or NDMA, which can cause cancer. Last year, a reformulated ranitidine tablet was approved by the FDA, marking its return.